PATH works to ensure that diagnostic tools to improve malaria case management and contribute to elimination are available and accessible to malaria endemic populations. We collaborate with partners to develop, evaluate, and commercialize highly sensitive tests to detect low-density infections and point-of-care tests for G6PD deficiency to guide treatment of patients with Plasmodium vivax. PATH makes available biological materials for test developers and materials to support implementation of diagnostic testing, as well as market and technology landscapes of malaria diagnostics.
Below are resources developed for our partners. New resources are added on a regular basis. If you do not see the resource you are looking for, please contact email@example.com.
Standard Operating Procedures: